Additional file 1 of Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia

Additional file 1: Supplementary Table S1. Statistical results of Student’s T-test for TNFAIP2 expression level among different subtypes of AML patients from TCGA cohort in the distribution of FAB classifications. The results were analyzed by UALCAN. Supplementary Table S2. Statistical results of Student’s T-test for TNFAIP2 expression level among different subtypes of AML patients in the microarray data of GSE14468 from the GEO database in the distribution of FAB classifications. Supplementary Table S3. The co-expressed genes associated with TNFAIP2 expression in AML. Supplementary Table S4. The differentially expressed genes between the TNFAIP2high and TNFAIP2low group of AML patients. Supplementary Table S5. The overlapping genes between significantly co-expressed genes and significantly differentially expressed genes of TNFAIP2 in AML.